Fresenius SE KGaA (XSWX:FRE) Long-Term Debt: CHF7,564 Mil (As of Mar. 2026)


XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
71 GF Score
Price CHF36.15
GF Value CHF33.18
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Long-Term Debt?

Fresenius SE KGaA XSWX:FRE 71 Long-Term Debt is CHF7,564 Mil as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 71/100 and a GF Value™ of CHF33.18 (Fairly Valued). The stock has 5 warning signs investors should review.

Fresenius SE KGaA's Long-Term Debt for the quarter that ended in Mar. 2026 was CHF7,564 Mil.

Fresenius SE KGaA's quarterly Long-Term Debt declined from Sep. 2025 (CHF8,908 Mil) to Dec. 2025 (CHF8,604 Mil) and declined from Dec. 2025 (CHF8,604 Mil) to Mar. 2026 (CHF7,564 Mil).

Fresenius SE KGaA's annual Long-Term Debt declined from Dec. 2023 (CHF10,805 Mil) to Dec. 2024 (CHF8,848 Mil) and declined from Dec. 2024 (CHF8,848 Mil) to Dec. 2025 (CHF8,604 Mil).

Fresenius SE KGaA  (XSWX:FRE) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Fresenius SE KGaA Long-Term Debt Related Terms

Fresenius SE KGaA Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Long-Term Debt Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17,301.27 18,736.61 10,804.81 8,847.85 8,603.53

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,637.45 8,733.22 8,907.54 8,603.53 7,564.45
XSWX:FRE
71GF Score
Fresenius SE & Co KGaA XSWX:FRE
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of CHF7,564 Mil mean?
Fresenius SE KGaA (XSWX:FRE) has a Long-Term Debt of CHF7,564 Mil as of Mar. 2026.
Is Fresenius SE KGaA's Long-Term Debt too high?
Fresenius SE KGaA's current Long-Term Debt is CHF7,564 Mil. Overall, Fresenius SE KGaA has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Long-Term Debt compare to HCA and THC?
Fresenius SE KGaA's Long-Term Debt of CHF7,564 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Fresenius SE KGaA's current Long-Term Debt is CHF7,564 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XSWX:FRE) is currently considered Fairly Valued. The stock's GF Value™ is CHF33.18, compared to a current price of CHF36.15 — trading 9% above its estimated fair value. The current Long-Term Debt is CHF7,564 Mil. Fresenius SE KGaA's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Long-Term Debt is CHF7,564 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF36.15 is trading 9% above its estimated GF Value™ of CHF33.18. GuruFocus considers Fresenius SE KGaA to be Fairly Valued.

Key valuation signals for XSWX:FRE:

  • Long-Term Debt: CHF7,564 Mil
  • GF Value™: CHF33.18 vs. price of CHF36.15 (9% above fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
71GF Score

Get the complete analysis for XSWX:FRE

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF36.15
Price
CHF33.18
GF Value